AU Patent

AU2018365241B2 — Process for preparing tapinarof

Assigned to Dermavant Sciences GmbH · Expires 2023-09-14 · 3y expired

What this patent protects

The present invention provides processes for the preparation of 3, 5-Dihydroxy-4-isopropyl-

USPTO Abstract

The present invention provides processes for the preparation of 3, 5-Dihydroxy-4-isopropyl-

Drugs covered by this patent

Patent Metadata

Patent number
AU2018365241B2
Jurisdiction
AU
Classification
—
Expires
2023-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Dermavant Sciences GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.